Fairmount Funds Management LLC

CIK 1802528 · last filed 2026-06-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$300.18M

Companies

8

Total Filings

22

Lifetime Open-Market Net

$270.05M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
JBIO Director $15.34 $0 1 2026-06-11
VRDN Director 5,090,928 $16.35 $83.24M $279.99M 6 2026-05-13
COGT Director 5,503,418 $33.10 $182.16M -$82.90M 7 2026-01-22
CRESCENT BIOPHARMA, INC. (GLYC) Delisted Director 2,747,866 $15.70 $43.14M $72.95M 1 2025-12-08
APGE Director $88.33 $0 1 2025-06-20
SYRE Director 367,378 $80.79 $29.68M $0 2 2024-05-16
DNTH Director 62,146 $82.07 $5.10M $0 2 2024-04-01
Cogent Biosciences, Inc. (UMRX) Delisted 10%+ Owner 1,147,406 $0 2 2020-07-13

Recent Filings · Page 3 of 3

22 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-07-13 Cogent Biosciences, Inc. (UMRX) Delisted Buy (P) $0 EDGAR
2020-07-08 Cogent Biosciences, Inc. (UMRX) Delisted Other (J) +6,235,903 $0 EDGAR
Showing 2122 of 22
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.